15 minutes delayed
Comments
Loading...
DECIPHERA PHARMACEUTICALS INC COM
DCPHNASDAQ
DECIPHERA PHARMACEUTICALS INC COM (NASDAQ:DCPH) Stock, Insider Trading Activity
DECIPHERA PHARMACEUTICALS INC COM: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are DECIPHERA PHARMACEUTICALS INC COM Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for DECIPHERA PHARMACEUTICALS INC COM
| Feb 20, 2024 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | 14.66K | $15.62 | -$40.84K | GRANT | 15.58% | 108.74K | Feb 15 - Feb 16 | View |
| Feb 20, 2024 | Patrick Thomas Kelly | CHIEF FINANCIAL OFFICER | 14.27K | $15.62 | -$47.01K | GRANT | 21.59% | 80.35K | Feb 15 - Feb 16 | View |
| Feb 20, 2024 | Jama Pitman | SVP, CHIEF DEVELOPMENT OFFICER | 17.46K | $15.62 | -$35.41K | GRANT | 34.52% | 68.03K | Feb 15 - Feb 16 | View |
| Feb 20, 2024 | Daniel Martin | CHIEF COMMERCIAL OFFICER | 7.46K | $15.62 | -$35.41K | GRANT | 15.65% | 55.12K | Feb 15 - Feb 16 | View |
| Jan 18, 2024 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | -2.44K | $14.47 | -$35.23K | SELL | -2.52% | 94.08K | Jan 16 | View |
| Jan 18, 2024 | Jama Pitman | SVP, CHIEF DEVELOPMENT OFFICER | -1.62K | $14.47 | -$23.50K | SELL | -3.11% | 50.57K | Jan 16 | View |
| Jan 18, 2024 | Patrick Thomas Kelly | CHIEF FINANCIAL OFFICER | -2.44K | $14.47 | -$35.23K | SELL | -3.55% | 66.08K | Jan 16 | View |
| Jan 18, 2024 | Daniel Martin | CHIEF COMMERCIAL OFFICER | -1.62K | $14.47 | -$23.50K | SELL | -3.30% | 47.66K | Jan 16 | View |
| Dec 14, 2023 | Steven Hoerter | PRESIDENT AND CEO | 31.84K | $15.37 | -$471.22K | GRANT | 77.79% | 72.76K | Dec 12 - Dec 13 | View |
| Dec 14, 2023 | Patrick Thomas Kelly | CHIEF FINANCIAL OFFICER | 5.45K | $15.37 | -$42.90K | GRANT | 8.64% | 68.52K | Dec 12 - Dec 13 | View |
| Dec 14, 2023 | Jama Pitman | SEE REMARKS | 3.91K | $15.37 | -$25.54K | GRANT | 8.11% | 52.20K | Dec 12 - Dec 13 | View |
| Dec 14, 2023 | Daniel Martin | CHIEF COMMERCIAL OFFICER | 3.85K | $15.37 | -$26.54K | GRANT | 8.47% | 49.28K | Dec 12 - Dec 13 | View |
| Dec 14, 2023 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | 5.45K | $15.37 | -$42.90K | GRANT | 5.99% | 96.51K | Dec 12 - Dec 13 | View |
| Dec 01, 2023 | Daniel Martin | CHIEF COMMERCIAL OFFICER | -17.80K | $12.57 | -$223.76K | SELL | -28.15% | 45.44K | Nov 30 | View |
| Oct 31, 2023 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | 5.88K | $12.02 | -$28.36K | GRANT | 6.94% | 90.63K | Oct 28 - Oct 30 | View |
| Oct 31, 2023 | Jama Pitman | SEE REMARKS | 4.17K | $12.02 | -$16.91K | GRANT | 9.45% | 48.28K | Oct 28 - Oct 30 | View |
| Oct 31, 2023 | Daniel Martin | CHIEF COMMERCIAL OFFICER | 4.17K | $12.02 | -$16.91K | GRANT | 7.10% | 62.88K | Oct 28 - Oct 30 | View |
| Oct 31, 2023 | Patrick Thomas Kelly | CHIEF FINANCIAL OFFICER | 5.93K | $12.02 | -$27.83K | GRANT | 10.37% | 63.07K | Oct 28 - Oct 30 | View |
| Oct 31, 2023 | Steven Hoerter | PRESIDENT AND CEO | 40.93K | $12.02 | -$259.26K | GRANT | ∞ | 40.93K | Oct 28 - Oct 30 | View |
| Oct 04, 2023 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | -2.94K | $12.68 | -$37.30K | SELL | -3.36% | 84.74K | Oct 02 | View |
| Jun 21, 2023 | Jama Pitman | SEE REMARKS | -1.24K | $14.40 | -$17.83K | SELL | -2.75% | 43.81K | Jun 16 | View |
| Jun 21, 2023 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | -1.66K | $14.40 | -$23.83K | SELL | -1.85% | 87.69K | Jun 16 | View |
| Jun 21, 2023 | Patrick Thomas Kelly | CHIEF FINANCIAL OFFICER | -1.66K | $14.40 | -$23.83K | SELL | -2.81% | 57.14K | Jun 16 | View |
| Jun 21, 2023 | Daniel Martin | CHIEF COMMERCIAL OFFICER | -1.24K | $14.40 | -$17.83K | SELL | -2.08% | 58.41K | Jun 16 | View |
| Jun 21, 2023 | Lee Daniel Flynn | CHIEF SCIENTIFIC OFFICER | -1.66K | $14.40 | -$23.83K | SELL | -1.53% | 106.65K | Jun 16 | View |
| Jun 12, 2023 | Stuart Franklin Friedman | DIRECTOR | 10.00K | $13.88 | $138.83K | BUY | ∞ | 10.00K | Jun 08 | View |
| May 12, 2023 | Leo Dennis Walsh | DIRECTOR | 11.00K | $13.86 | $152.42K | BUY | ∞ | 11.00K | May 10 | View |
| Mar 23, 2023 | Steven Hoerter | PRESIDENT AND CEO | -7.50K | $15.57 | -$116.78K | SELL | -100.00% | 0.00 | Mar 21 | View |
| Feb 17, 2023 | Jama Pitman | SEE REMARKS | 9.99K | $15.10 | -$17.50K | GRANT | 28.50% | 45.05K | Feb 15 - Feb 16 | View |
| Feb 17, 2023 | Daniel Martin | CHIEF COMMERCIAL OFFICER | 9.99K | $15.10 | -$17.50K | GRANT | 20.65% | 58.38K | Feb 15 - Feb 16 | View |
| Feb 17, 2023 | Patrick Thomas Kelly | CHIEF FINANCIAL OFFICER | 15.12K | $15.10 | -$20.69K | GRANT | 34.61% | 58.80K | Feb 15 - Feb 16 | View |
| Feb 17, 2023 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | 15.52K | $15.10 | -$14.66K | GRANT | 21.37% | 88.14K | Feb 15 - Feb 16 | View |
| Feb 17, 2023 | Lee Daniel Flynn | CHIEF SCIENTIFIC OFFICER | 15.12K | $15.10 | -$20.69K | GRANT | 11.22% | 149.83K | Feb 15 - Feb 16 | View |
| Feb 16, 2023 | Steven Hoerter | PRESIDENT AND CEO | -30.05K | $16.00 | -$480.72K | SELL | -80.02% | 7.50K | Feb 14 | View |
| Jan 24, 2023 | Brightstar Associates LLC | 10% OWNER | 1.67M | $18.00 | $30.00M | BUY | 9.23% | 19.72M | Jan 24 | View |
| Jan 19, 2023 | Lee Daniel Flynn | CHIEF SCIENTIFIC OFFICER | -2.40K | $21.24 | -$51.04K | SELL | -1.75% | 134.72K | Jan 17 | View |
| Jan 19, 2023 | Jama Pitman | SEE REMARKS | -1.60K | $21.24 | -$34.05K | SELL | -4.37% | 35.06K | Jan 17 | View |
| Jan 19, 2023 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | -2.40K | $21.24 | -$51.04K | SELL | -3.20% | 72.63K | Jan 17 | View |
| Jan 19, 2023 | Daniel Martin | CHIEF COMMERCIAL OFFICER | -1.60K | $21.24 | -$34.05K | SELL | -3.21% | 48.39K | Jan 17 | View |
| Jan 19, 2023 | Patrick Thomas Kelly | CHIEF FINANCIAL OFFICER | -2.40K | $21.24 | -$51.04K | SELL | -5.21% | 43.68K | Jan 17 | View |
| Oct 05, 2022 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | -2.59K | $18.73 | -$48.45K | SELL | -3.36% | 74.30K | Oct 03 | View |
| Jun 21, 2022 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | -1.77K | $10.75 | -$19.01K | SELL | -2.25% | 76.88K | Jun 16 | View |
| Jun 21, 2022 | Jama Pitman | SEE REMARKS | -1.30K | $10.75 | -$13.95K | SELL | -3.42% | 36.66K | Jun 16 | View |
| Jun 21, 2022 | Daniel Martin | CHIEF COMMERCIAL OFFICER | -1.31K | $10.75 | -$14.09K | SELL | -2.58% | 49.52K | Jun 16 | View |
| Jun 21, 2022 | Patrick Thomas Kelly | CHIEF FINANCIAL OFFICER | -1.77K | $10.75 | -$19.01K | SELL | -3.70% | 46.08K | Jun 16 | View |
| Jun 21, 2022 | Lee Daniel Flynn | CHIEF SCIENTIFIC OFFICER | -1.77K | $10.75 | -$19.01K | SELL | -1.27% | 137.12K | Jun 16 | View |
| Apr 29, 2022 | Brightstar Associates LLC | 10% OWNER | 1.48M | $10.00 | $14.79M | BUY | 8.92% | 18.05M | Apr 29 | View |
| Feb 18, 2022 | Lee Daniel Flynn | CHIEF SCIENTIFIC OFFICER | -1.37K | $9.05 | -$12.36K | SELL | -0.97% | 138.89K | Feb 16 | View |
| Feb 18, 2022 | Daniel Martin | CHIEF COMMERCIAL OFFICER | -1.15K | $9.05 | -$10.37K | SELL | -2.30% | 48.67K | Feb 16 | View |
| Feb 18, 2022 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | -984.00 | $9.05 | -$8.91K | SELL | -1.27% | 76.79K | Feb 16 | View |
| Feb 18, 2022 | Patrick Thomas Kelly | CHIEF FINANCIAL OFFICER | -1.37K | $9.05 | -$12.38K | SELL | -2.78% | 47.85K | Feb 16 | View |
| Feb 18, 2022 | Jama Pitman | SEE REMARKS | -1.15K | $9.05 | -$10.37K | SELL | -2.93% | 37.96K | Feb 16 | View |
| Oct 06, 2021 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | -2.66K | $33.17 | -$88.20K | SELL | -5.46% | 46.03K | Oct 04 | View |
| May 05, 2021 | Douglas Michael Taylor | DIRECTOR | 0.00 | $24.72 | -$341.99K | SELL-OPTIONS | 0.00% | 0.00 | May 03 | View |
| Apr 21, 2021 | Arthur James Bristol | DIRECTOR | 0.00 | $25.02 | -$295.04K | SELL-OPTIONS | 0.00% | 0.00 | Apr 19 - Apr 20 | View |
| Apr 14, 2021 | Arthur James Bristol | DIRECTOR | 0.00 | $23.89 | -$586.35K | SELL-OPTIONS | 0.00% | 0.00 | Apr 12 | View |
| Apr 06, 2021 | Douglas Michael Taylor | DIRECTOR | 0.00 | $23.73 | -$349.45K | SELL-OPTIONS | 0.00% | 0.00 | Apr 01 | View |
| Mar 03, 2021 | Douglas Michael Taylor | DIRECTOR | 0.00 | $22.96 | -$337.19K | SELL-OPTIONS | 0.00% | 0.00 | Mar 01 | View |
| Feb 18, 2021 | Thomas P. Kelly | CHIEF FINANCIAL OFFICER | 10.58K | $48.87 | -$25.61K | GRANT | 150.23% | 17.62K | Feb 16 | View |
| Feb 18, 2021 | Lee Daniel Flynn | CHIEF SCIENTIFIC OFFICER | 10.59K | $48.87 | -$24.83K | GRANT | 10.80% | 108.65K | Feb 16 | View |
| Feb 18, 2021 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | 10.97K | $48.87 | -$6.45K | GRANT | 29.31% | 48.39K | Feb 16 | View |
| Feb 03, 2021 | Douglas Michael Taylor | DIRECTOR | 0.00 | $23.56 | -$346.75K | SELL-OPTIONS | 0.00% | 0.00 | Feb 01 | View |
| Jan 20, 2021 | Arthur James Bristol | DIRECTOR | 0.00 | $27.12 | -$324.39K | SELL-OPTIONS | 0.00% | 0.00 | Jan 15 | View |
| Jan 06, 2021 | Douglas Michael Taylor | DIRECTOR | 0.00 | $29.17 | -$1.04M | SELL-OPTIONS | 0.00% | 0.00 | Jan 04 | View |
| Dec 03, 2020 | Douglas Michael Taylor | — | 0.00 | $31.40 | -$1.12M | OPTION EXERCISE | 0.00% | 0.00 | Dec 01 | View |
| Nov 06, 2020 | Douglas Michael Taylor | — | 0.00 | $33.34 | -$943.64K | OPTION EXERCISE | 0.00% | 0.00 | Nov 04 | View |
| Nov 04, 2020 | Douglas Michael Taylor | — | 0.00 | $29.77 | -$1.30M | OPTION EXERCISE | 0.00% | 0.00 | Nov 02 | View |
| Oct 13, 2020 | Arthur James Bristol | — | 0.00 | $27.73 | -$1.22M | OPTION EXERCISE | 0.00% | 0.00 | Oct 09 | View |
| Oct 05, 2020 | Douglas Michael Taylor | — | 0.00 | $26.75 | -$6.21M | OPTION EXERCISE | 0.00% | 0.00 | Oct 01 | View |
| Sep 16, 2020 | Thomas P. Kelly | — | 0.00 | $25.95 | -$144.37K | OPTION EXERCISE | 0.00% | 7.04K | Sep 14 | View |
| Sep 10, 2020 | Thomas P. Kelly | — | 0.00 | $24.06 | -$399.05K | OPTION EXERCISE | 0.00% | 7.04K | Sep 08 - Sep 10 | View |
| Jul 13, 2020 | Arthur James Bristol | — | 0.00 | $28.44 | -$1.25M | OPTION EXERCISE | 0.00% | 0.00 | Jul 09 | View |
| Jul 06, 2020 | Douglas Michael Taylor | — | 0.00 | $29.56 | -$6.92M | OPTION EXERCISE | 0.00% | 0.00 | Jul 01 - Jul 06 | View |
| Jun 05, 2020 | Patricia Allen | — | 0.00 | $41.68 | -$382.69K | OPTION EXERCISE | 0.00% | 0.00 | Jun 03 - Jun 05 | View |
| May 13, 2020 | Thomas P. Kelly | — | 0.00 | $28.54 | -$639.56K | OPTION EXERCISE | 0.00% | 7.04K | May 11 | View |
| Apr 30, 2020 | Douglas Michael Taylor | — | 0.00 | $29.39 | -$1.38M | OPTION EXERCISE | 0.00% | 0.00 | Apr 28 | View |
| Apr 21, 2020 | Douglas Michael Taylor | — | 0.00 | $24.28 | -$1.07M | OPTION EXERCISE | 0.00% | 0.00 | Apr 17 | View |
| Apr 16, 2020 | Douglas Michael Taylor | — | 0.00 | $24.30 | -$49.66K | OPTION EXERCISE | 0.00% | 0.00 | Apr 14 | View |
| Apr 13, 2020 | Arthur James Bristol | — | 0.00 | $22.86 | -$987.35K | OPTION EXERCISE | 0.00% | 0.00 | Apr 09 | View |
| Apr 03, 2020 | Douglas Michael Taylor | — | 0.00 | $19.73 | -$2.68M | OPTION EXERCISE | 0.00% | 0.00 | Apr 01 | View |
| Jan 28, 2020 | Patricia Allen | — | 0.00 | $35.04 | -$1.55M | DERIVATIVE CONVERSION | 0.00% | 0.00 | Jan 24 | View |
| Jan 24, 2020 | Daniel Martin | — | 0.00 | $51.64 | -$839.05K | OPTION EXERCISE | 0.00% | 17.00K | Jan 22 | View |
| Jan 17, 2020 | John Christopher Morl | — | 0.00 | $34.61 | -$921.82K | OPTION EXERCISE | 0.00% | 0.00 | Jan 15 - Jan 16 | View |
| Jan 09, 2020 | John Christopher Morl | — | 0.00 | $32.03 | -$782.28K | OPTION EXERCISE | 0.00% | 0.00 | Jan 07 - Jan 08 | View |
| Jan 06, 2020 | John Christopher Morl | — | 0.00 | $31.25 | -$881.13K | OPTION EXERCISE | 0.00% | 0.00 | Jan 02 | View |
| Jan 06, 2020 | Douglas Michael Taylor | — | 0.00 | $29.80 | -$6.98M | OPTION EXERCISE | 0.00% | 0.00 | Jan 02 - Jan 03 | View |
| Jan 06, 2020 | Thomas P. Kelly | — | 0.00 | $29.77 | -$669.06K | OPTION EXERCISE | 0.00% | 0.00 | Jan 02 - Jan 03 | View |
| Jan 06, 2020 | Arthur James Bristol | — | 0.00 | $29.78 | -$1.31M | OPTION EXERCISE | 0.00% | 0.00 | Jan 02 - Jan 03 | View |
| Dec 26, 2019 | Thomas P. Kelly | CHIEF FINANCIAL OFFICER | 0.00 | $35.05 | -$2.65M | SELL-OPTIONS | 0.00% | 0.00 | Dec 23 | View |
| Dec 13, 2019 | Lee Daniel Flynn | CHIEF SCIENTIFIC OFFICER | -31.03K | $60.00 | -$1.86M | SELL | -33.99% | 60.25K | Dec 12 | View |
| Dec 13, 2019 | John Christopher Morl | CHIEF BUSINESS OFFICER | 0.00 | $31.98 | -$842.66K | SELL-OPTIONS | 0.00% | 0.00 | Dec 12 | View |
| Dec 11, 2019 | John Christopher Morl | CHIEF BUSINESS OFFICER | 0.00 | $29.48 | -$767.49K | SELL-OPTIONS | 0.00% | 0.00 | Dec 09 - Dec 10 | View |
| Dec 11, 2019 | Lee Daniel Flynn | CHIEF SCIENTIFIC OFFICER | 0.00 | $28.45 | -$8.12M | SELL-OPTIONS | 0.00% | 79.77K | Dec 09 - Dec 10 | View |
| Dec 05, 2019 | John Christopher Morl | CHIEF BUSINESS OFFICER | 0.00 | $50.00 | -$751.76K | SELL-OPTIONS | 0.00% | 0.00 | Dec 03 | View |
| Nov 13, 2019 | Lee Daniel Flynn | CHIEF SCIENTIFIC OFFICER | 0.00 | $24.95 | -$7.05M | SELL-OPTIONS | 0.00% | 79.77K | Nov 08 - Nov 11 | View |
| Nov 05, 2019 | Douglas Michael Taylor | DIRECTOR | 0.00 | $23.45 | -$323.47K | SELL-OPTIONS | 0.00% | 0.00 | Nov 01 | View |
| Nov 05, 2019 | Arthur James Bristol | DIRECTOR | 0.00 | $23.48 | -$1.08M | SELL-OPTIONS | 0.00% | 0.00 | Nov 01 | View |
| Oct 30, 2019 | Lee Daniel Flynn | CHIEF SCIENTIFIC OFFICER | 0.00 | $20.95 | -$1.14M | SELL-OPTIONS | 0.00% | 79.77K | Oct 28 | View |
| Oct 30, 2019 | Thomas P. Kelly | CHIEF FINANCIAL OFFICER | 0.00 | $20.95 | -$142.92K | SELL-OPTIONS | 0.00% | 0.00 | Oct 28 | View |
| Sep 23, 2019 | Daniel Martin | CHIEF COMMERCIAL OFFICER | -3.00K | $35.56 | -$106.69K | SELL | -15.00% | 17.00K | Sep 19 | View |
| Sep 13, 2019 | Thomas P. Kelly | CHIEF FINANCIAL OFFICER | 0.00 | $18.43 | -$372.18K | SELL-OPTIONS | 0.00% | 0.00 | Sep 11 | View |
| Sep 13, 2019 | Douglas Michael Taylor | DIRECTOR | 0.00 | $18.43 | -$744.31K | SELL-OPTIONS | 0.00% | 0.00 | Sep 11 | View |
| Sep 05, 2019 | Douglas Michael Taylor | DIRECTOR | 0.00 | $19.08 | -$257.80K | SELL-OPTIONS | 0.00% | 0.00 | Sep 03 | View |
| Aug 19, 2019 | New Leaf Venture Management III LLCNew Leaf Ventures III LPNew Leaf Biopharma Opportunities I LPNew Leaf Venture Associates III LPNew Leaf BPO Associates I LP | 10% OWNER | -350.00K | $36.42 | -$12.75M | SELL | -15.13% | 1.96M | Aug 15 - Aug 16 | View |
| Aug 13, 2019 | Douglas Michael Taylor | DIRECTOR | 0.00 | $21.33 | -$874.82K | SELL-OPTIONS | 0.00% | 0.00 | Aug 13 | View |
| Aug 13, 2019 | Thomas P. Kelly | CHIEF FINANCIAL OFFICER | 0.00 | $21.58 | -$442.99K | SELL-OPTIONS | 0.00% | 0.00 | Aug 13 | View |
| Aug 13, 2019 | Lee Daniel Flynn | CHIEF SCIENTIFIC OFFICER | -25.00K | $21.41 | -$5.83M | SELL | -17.00% | 122.05K | Aug 13 | View |
| Aug 13, 2019 | Arthur James Bristol | DIRECTOR | 0.00 | $20.93 | -$952.12K | SELL-OPTIONS | 0.00% | 0.00 | Aug 13 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.